Fox Run Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-490
| Closed | -$54.9K | – | 958 |
|
|
2024
Q1 | $54.9K | Buy |
+490
| New | +$54.9K | 0.01% | 713 |
|
|
2023
Q4 | – | Sell |
-873
| Closed | -$27.7K | – | 907 |
|
|
2023
Q3 | $27.7K | Buy |
+873
| New | +$27.7K | 0.01% | 663 |
|
|
2023
Q1 | – | Sell |
-986
| Closed | -$144K | – | 835 |
|
|
2022
Q4 | $144K | Buy |
986
+503
| +104% | +$73.7K | 0.06% | 530 |
|
|
2022
Q3 | $82K | Buy |
+483
| New | +$82K | 0.03% | 562 |
|
|
2021
Q4 | – | Sell |
-471
| Closed | -$111K | – | 621 |
|
|
2021
Q3 | $111K | Buy |
+471
| New | +$111K | 0.07% | 423 |
|